Epilepsy is primarily treated symptomatically—that is, the majority of the available medications aim to suppress seizures ...

Epilepsy is primarily treated symptomatically - that is, the majority of the available medications aim to suppress seizures ...

The defects in molecular and cellular processes that constitute the triggers of specific pathologies are referred to as mechanisms of disease. Research in this area is vital for designing ...

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, ...

The second trial, codenamed PIONEER 7, faced off market dominating Januvia developed and marketed by Merck & Co. The results showed 63% patients medicated with semaglutide, achieved target HbA1C ...

Patient organisations have been celebrating the FDA approval yesterday of Amylyx' amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that ...